HDFC Pharma and Healthcare Fund vs Tata India Pharma & Healthcare Fund compare
HDFC Pharma and Healthcare Fund - Regular (G)
Tata India Pharma & Healthcare Fund-Regular Plan-Growth
Chart Comparison
Overview
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Fund | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
| Investment Plan | Growth | Growth |
| Level of Risk | Very High | Very High |
| Asset Size (Cr) | ₹2011 Cr | ₹1339 Cr |
| Min Investment | ₹100 | ₹5000 |
| Min SIP Invesment | ₹100 | ₹100 |
| Min Addl Investment | ₹100 | ₹1000 |
| Launch Date | 04 Oct 2023 | 28 Dec 2015 |
| Category | Pharma & Healthcare | Pharma & Healthcare |
| Fund Type | Open Ended | Open Ended |
| Benchmark | BSE Healthcare Index | Nifty Pharma TRI |
| Turn Over | % | 26.49% |
| Expense Ratio | 2.14 | 2.14 |
| Manager | Dhruv Muchhal | Meeta Shetty |
| ISIN Code | INF179KC1HL7 | INF277K016A9 |
| Exits Load | HDFC Pharma and Healthcare Fund - Regular Plan - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | Tata India Pharma & Heathcare Fund - Growth charges 0.25% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Month | -0.5% | -0.97% |
| 6 Month | 5.66% | 2.81% |
| 1 Year | 4.39% | -1.88% |
| 3 Year | - | 21.85% |
| 5 Year | - | 15.02% |
SIP Return Analysis
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 6 Month | -1.12% | -2.36% |
| 1 Year | 7.48% | 1.94% |
| 3 Year | - | 16.49% |
| 5 Year | - | 16.5% |
Rolling Lumpsum Returns
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| 1 Year | 27.59% | 8.33% |
| 3 Year | - | 18.87% |
| 5 Year | - | 15.74% |
Risk Management
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Standard Deviation | - | 16.04% |
| Sharp | - | 0.91% |
| Beta | - | 0.98% |
| Alpha | - | -1.01% |
Fund Managers
| Scheme Name | HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Name | Dhruv Muchhal | Meeta Shetty |
| Total AUM | ₹520687 Cr | ₹17847 Cr |
| Funds Managed | 40 | 5 |
| HDFC Pharma and Healthcare Fund - Regular (G) | Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
Market Cap
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 10.4 | 6.27 |
| Mid Cap | 30.37 | 39.01 |
| Small Cap | 32.94 | 35.21 |
| Large Cap | 26.28 | 19.5 |
Sector Allocation
| Scheme Name |
HDFC Pharma and Healthcare Fund - Regular (G) |
Tata India Pharma & Healthcare Fund-Regular Plan-Growth |
|---|---|---|
| Others | 1.62 | 5.02 |
| Basic Materials | 2.97 | 4.14 |
| Healthcare | 95.41 | 90.83 |
Top Comparisons
ICICI Prudential Multi-Asset Fund - Growth
3Y Returns20.12%
HDFC Multi-Asset Allocation Fund - Growth Option
3Y Returns15.36%
UTI Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.38%
Baroda BNP Paribas Short Duration Fund - Regular Plan - Growth Option
3Y Returns7.37%
Franklin India Liquid Fund - Super Institutional Plan - Growth
3Y Returns6.98%
Franklin India Liquid Fund - Super Institutional Plan - Growth
3Y Returns6.98%
WhiteOak Capital Multi Asset Allocation Fund-Reg (G)
3Y Returns0%
Edelweiss Multi Asset Allocation Fund - Reg (G)
3Y Returns0%